Company Monitoring Page for Otsuka

latest headlines for company on cafepharma

Drugmakers Lundbeck, Otsuka form global alliance
Reuters
Fri, 11/11/11 - 09:46 am
Tags:
Otsuka, Lundbeck, aripiprazole depot, OPC-34712
Otsuka Sets Price for $2.4 Billion Tokyo IPO at the Lower End of Its Range
Bloomberg
Mon, 12/6/10 - 11:30 am
Tags:
Otsuka, Japan, IPOs
Bristol-Myers, Otsuka's Schizophrenia Drug Backed for Teens by U.K. Agency
Bloomberg
Wed, 12/1/10 - 08:08 am
Tags:
Bristol-Myers Squibb, Otsuka, schizophrenia, aripiprazole, UK, Abilify
Bristol-Myers Partner Otsuka Wins Abilify Ruling
Bloomberg
Tue, 11/16/10 - 09:36 am
Tags:
Otsuka, Bristol-Myers Squibb, Abilify, patents, Teva Pharmaceuticals, Sun Pharma, Sandoz, Apotex
MethylGene Reports Third Quarter 2010 Financial Results and Provides Clinical Update for MGCD265
PR-USA.net
Sun, 11/14/10 - 01:09 pm
Tags:
MethylGene, earnings, Otsuka, MGCD265, cancer
Otsuka plots $2.8B IPO
Fierce Biotech
Fri, 11/12/10 - 09:51 am
Tags:
IPOs, Otsuka
Otsuka Said to Hire Morgan Stanley, Nomura, UBS to Manage Drugmaker's IPO
Bloomberg
Thu, 09/2/10 - 04:21 pm
Tags:
Japan, Otsuka, IPOs
SPRYCEL® (dasatinib) Receives FDA Priority Review for the Treatment of Adult Patients with Newly Diagnosed Chronic Myeloid Leukemia (CML) in Chronic Phase
Yahoo/BusinessWire
Sat, 07/10/10 - 11:39 am
Tags:
Sprycel, chronic myeloid leukemia, BMS, Otsuka
Otsuka Pharma extends research collaboration with MethylGene
Pharmabiz
Sat, 07/3/10 - 10:50 am
Tags:
Otsuka, MethylGene, eye disease
SPRYCEL(R) (dasatinib) Demonstrates Superior Confirmed Complete Cytogenetic Response Rates Compared to Gleevec(R)* in Study of Adult Patients with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase
BusinessWire
Sat, 06/5/10 - 12:24 pm
Tags:
chronic myeloid leukemia, Sprycel, dasatinib, Gleevac, BMS, Otsuka
COPD Drug Class Gasping for Breath
WSJ Online
Thu, 04/8/10 - 10:47 am
Tags:
COPD, Forest Labs, Nycomed, Otsuka, Glenmark, Orexo
Bristol an Attractive Value
Yahoo/Zacks.com
Thu, 04/9/09 - 10:15 am
Tags:
Bristol-Myers Squibb, Otsuka, Exelixis, ZymoGenetics, Sanofi, AstraZeneca
Abilify Deal Gives Bristol-Myers Some Breathing Room
WSJ Online
Mon, 04/6/09 - 09:25 am
Tags:
Abilify, Bristol-Myers Squibb, Otsuka, antipsychotics
Bristol-Myers Extends Partnership on Abilify
CNBC
Mon, 04/6/09 - 08:35 am
Tags:
Bristol-Myers Squibb, Otsuka, Abilify, partnerships
Newer schizophrenia drugs cause heart risks: study
Reuters, UK
Wed, 01/14/09 - 08:12 pm
Tags:
schizophrenia, Eli Lilly, Abilify, Zyprexa, Otsuka, Bristol-Myers Squibb

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.